Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Jun. 30, 2022
ASSETS
Cash and cash equivalents	$ 6,048,001	$ 16,249,666
Investments	247,511	239,314
Accounts receivable	1,551,355	1,332,922
Deferred costs/contract assets	72,436	39,484
Prepaid expenses and other current assets	581,518	389,618
Total current assets	8,500,821	18,251,004
Equipment, net	331,591	245,970
Note receivable		250,000
Right-of-use assets	936,338
Intangible assets, net	6,814,271	4,063,485
Goodwill	22,306,959	13,464,760
Other assets	71,769	121,865
Restricted cash	2,000,000	2,000,000
Total assets	40,961,749	38,397,084
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable	349,661	340,139
Accrued liabilities	343,906	188,417
Accrued bonuses	149,890	169,262
Deferred revenue/contract liabilities	529,898	841,389
Asset purchase payable		734,037
Lease liabilities, current portion	399,424
Contingent consideration for acquisitions, current portion	4,123,988	1,966,171
Total current liabilities	5,896,767	4,239,415
Long term liabilities
Contingent consideration for acquisitions, net of current portion	6,519,800	5,340,800
Lease liabilities, net of current portion	521,855
Total liabilities	12,938,422	9,580,215
Commitments and contingencies
Stockholders’ Equity
Preferred Stock, par value $0.001 per share, 20 million shares authorized; 0 shares issued and outstanding
Common Stock, par value $0.001 per share, 300 million shares authorized; 14,340,132 and 12,747,624 issued and outstanding	14,341	12,749
Additional paid-in capital	65,387,641	56,885,815
Accumulated deficit	(37,378,655)	(28,081,695)
Total stockholders’ equity	28,023,327	28,816,869
Total liabilities and stockholders’ equity	$ 40,961,749	$ 38,397,084